Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Ellis G Levine"'
Autor:
Lauren Williams, Paul K Wallace, Pawel Kalinski, Mateusz Opyrchal, Kathleen M Kokolus, Shipra Gandhi, Kristopher Attwood, Agnieszka Witkiewicz, Hans Minderman, Kah Teong Soh, Melissa J Grimm, Ronald T Slomba, Adrienne Groman, Mary Lynne Tarquini, Orla Maguire, Tracey L O’Connor, Amy P Early, Ellis G Levine
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 11 (2023)
Background Presence of cytotoxic T lymphocytes (CTL) in the tumor microenvironment (TME) predicts the effectiveness of cancer immunotherapies. The ability of toll-like receptor 3 (TLR3) ligands, interferons (IFNs) and COX2 inhibitors to synergistical
Externí odkaz:
https://doaj.org/article/2d1ecf8be6c34222ae25dc9f47cf3dc6
Autor:
Adith Abraham, Carlos H. Barcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis G. Levine, Nancy U. Lin, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, Sarah Asad, Daniel G. Stover
Publikováno v:
Breast, Vol 67, Iss , Pp 89-93 (2023)
Background: Most metastatic recurrences of triple negative breast cancer (TNBC) occur within five years of diagnosis, yet late relapses of TNBC (lrTNBC) do occur. Our objective was to develop a risk prediction model of lrTNBC using readily available
Externí odkaz:
https://doaj.org/article/5c83b462165b47969c3d65f9cfdccfde
Autor:
Sabah Alaklabi, Arya Mariam Roy, Kristopher Attwood, Anthony George, Tracey O’Connor, Amy Early, Ellis G. Levine, Shipra Gandhi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundIt is critically important to study the real-world data of FDA-approved medications to understand the response rates and toxicities observed in the real-world population not represented in the clinical trials.MethodsWe reviewed charts of pa
Externí odkaz:
https://doaj.org/article/e7f56b784faa4b85b0df5d1bf3c39650
Autor:
Jennifer K. Lang, Badri Karthikeyan, Adolfo Quiñones-Lombraña, Rachael Hageman Blair, Amy P. Early, Ellis G. Levine, Umesh C. Sharma, Javier G. Blanco, Tracey O’Connor
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Background The CBR3 V244M single nucleotide polymorphism has been linked to the risk of anthracycline-related cardiomyopathy in survivors of childhood cancer. There have been limited prospective studies examining the impact of CBR3 V244M on
Externí odkaz:
https://doaj.org/article/89fad400f0164475859f191de1cdfeae
Autor:
Ajay Dhakal, Roby Antony Thomas, Ellis G Levine, Adam Brufsky, Kazuaki Takabe, Matthew G Hanna, Kristopher Attwood, Austin Miller, Thaer Khoury, Amy P Early, Saif Soniwala, Tracy O’Connor, Mateusz Opyrchal
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 14 (2020)
Background: Despite the approval of mTOR inhibitor everolimus and CDK4/6 inhibitors in the management of hormone-receptor-positive HER2 non-amplified metastatic breast cancer (HR+ HER2-MBC), the optimal sequence of therapy is unclear. There are no cl
Externí odkaz:
https://doaj.org/article/ab6219d74f2a4b79adec209c9ce08069
Autor:
Adith S. Abraham, Carlos H. Barcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis G. Levine, Nancy U. Lin, Beverly Moy, Joyce Niland, Antonio C. Wolff, Michael J. Hassett, Daniel G. Stover, Sarah Asad
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:CLO22-033
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55f2ee1f0e29f35334bb2018252f62e4
https://doi.org/10.6004/jnccn.2021.7177
https://doi.org/10.6004/jnccn.2021.7177
Autor:
Maithreyi Sarma, Stuthi Perimbeti, Samar Nasir, Kristopher Attwood, Ankita Kapoor, Tracey O’Connor, Amy Early, Ellis G. Levine, Kazuaki Takabe, Pawel Kalinski, Christine Ambrosone, Thaer Khoury, Song Yao, Shipra Gandhi
Publikováno v:
Breast Cancer Res Treat
PURPOSE: To examine the association between race and clinical outcomes (pathological complete response [pCR]; recurrence free survival [RFS], and overall survival [OS]) in patients diagnosed with triple-negative (TNBC) or HER2-positive breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e08fc592d2e90b5b753c21eba0c36a
https://doi.org/10.1007/s10549-021-06506-y
https://doi.org/10.1007/s10549-021-06506-y
Autor:
Daniel G. Stover, Richard J. Bleicher, Nan Lin, Sara H. Javid, Sarah Asad, Carlos H. Barcenas, Beverly Moy, Adam L. Cohen, Ellis G. Levine, Antonio C. Wolff, Michael J. Hassett, Joyce C. Niland
Publikováno v:
Cancer Research. 80:P5-07
Background: Triple-negative breast cancer (TNBC) accounts for a disproportionate amount of poor outcomes among breast cancers. A subset of TNBCs demonstrates an aggressive course with marked chemoresistance, rapid distant metastatic spread, and poor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1edf30c41df94ce5ab4aaa3b5682ad07
https://doi.org/10.1158/1538-7445.sabcs19-p5-07-02
https://doi.org/10.1158/1538-7445.sabcs19-p5-07-02
Autor:
Lisa Blumencranz, Raye Budway, Michaela Tsai, Robin Zon, Joseph McKelley, Rubina Qamar, Hatem Soliman, Sarah Untch, B Mavromatis, Shelly S. Lo, Pat Whitworth, William Audeh, Ellis G. Levine
Publikováno v:
Cancer Research. 80:P2-14
Background: The PROMIS trial (NCT01617954) previously evaluated how a definitive result from the MammaPrint 70-gene signature (70-GS) can impact treatment recommendations for patients with an intermediate range recurrence score (RS 18-30) from the 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a96c27b8b2c134ce197434de4e04d307
https://doi.org/10.1158/1538-7445.sabcs19-p2-14-11
https://doi.org/10.1158/1538-7445.sabcs19-p2-14-11
Autor:
William Audeh, Varsha Shah, Rubina Qamar, Ellis G. Levine, Gordan Srkalovic, Reshma Mahtani, Sarah Untch, Heather M. Kling, Robert Gabordi, B Mavromatis, Tina Treece, Hatem Soliman, Mohamad Kassar, Jayanthi Srinivasiah
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Cancer
BMC Cancer
Background Increased usage of genomic risk assessment assays suggests increased reliance on data provided by these assays to guide therapy decisions. The current study aimed to assess the change in treatment decision and physician confidence based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b653e133220532b332a9ed5fb8fb852a
https://doaj.org/article/87a37eaf5e5243ac9fe1d0dcb516b31f
https://doaj.org/article/87a37eaf5e5243ac9fe1d0dcb516b31f